8-KLeadership ChangesExhibits & Filings

RTX Corp 8-K Report, Executive Changes (Apr 19, 2021)

Filed April 19, 2021For Securities:RTX

Summary

This 8-K filing from RTX Corp primarily announces the election of Bernard A. Harris, Jr. as an independent director to the Board, effective April 19, 2021. Dr. Harris's appointment will fill a vacancy and he will serve until the 2022 Annual Meeting of Shareowners. This addition to the board, particularly his roles on the Audit Committee and Special Activities Committee, suggests a focus on strengthening oversight and strategic financial review within the company. Investors should note that Dr. Harris's election appears to be a standard board refreshment rather than a response to any specific recent events or compensation arrangements. His compensation will align with the company's existing non-employee director compensation structure. The filing also confirms the inclusion of the related press release as an exhibit. Overall, this is a routine governance update aimed at enhancing board expertise.

Key Highlights

  • 1RTX Corp elected Bernard A. Harris, Jr. as an independent director, effective April 19, 2021.
  • 2Dr. Harris's term as director will expire at the 2022 Annual Meeting of Shareowners.
  • 3The newly elected director has been appointed to the Board's Audit Committee.
  • 4Dr. Harris will also serve on the Special Activities Committee.
  • 5The election was not based on any pre-existing arrangements with third parties.
  • 6Dr. Harris's compensation will be in line with the company's standard non-employee director compensation.
  • 7A press release detailing Dr. Harris's election is included as an exhibit to the filing.

Frequently Asked Questions

Bernard A. Harris, Jr. is an independent director elected to the RTX Corp Board. While the filing doesn't detail his specific background, his election is a standard part of board governance, likely aimed at bringing additional expertise and independent perspectives to the company's oversight, particularly in financial matters given his committee assignments.

The Audit Committee typically oversees financial reporting, internal controls, and the audit process, crucial for investor confidence. The Special Activities Committee's exact remit isn't detailed here but often handles unique or sensitive strategic matters. Dr. Harris's appointment to both suggests a focus on strengthening financial oversight and potentially addressing specific strategic initiatives.

No, the filing explicitly states that Dr. Harris's election was not pursuant to any arrangement or understanding with a third party, and he is not involved in any reportable transactions with the company or its affiliates. His compensation will follow the company's standard program for non-employee directors.

Based solely on this 8-K filing, the election of Dr. Harris appears to be a routine board refreshment activity rather than an indication of distress or a major strategic pivot. It is a common practice for public companies to add independent directors to enhance governance and bring diverse skills to the board.